Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NOTA-H006 PET Imaging in Malignant Tumors
NCT06162988Not yet recruiting
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Radiopharmaceutical, Positron Emission Tomography Imaging
- Countries
- 1
01
Overview
Open-label, single-arm trial of 68Ga-NOTA-H006. Primary endpoint: Establishment and optimization of imaging method for 68Ga-NOTA-H006 PET at 90 minutes. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
68Ga-NOTA-H006
Beyond the preview
Go deeper on NCT06162988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06162988.